Acquisitions17 Jul 2026, 05:00 pm
Jagsonpal Pharmaceuticals Completes Acquisition of Aequitas Healthcare
AI Summary
Jagsonpal Pharmaceuticals Ltd has announced the successful completion of its acquisition of an 85% equity stake in Aequitas Healthcare Private Limited. This follows previous intimations regarding the proposed acquisition dated June 29, 2026, and further updates on July 7 and July 8, 2026. The company has formally informed the stock exchange of this development and requested it be taken on record. This strategic move is expected to bolster Jagsonpal Pharmaceuticals' presence and capabilities within the healthcare sector.
Key Highlights
- Jagsonpal Pharmaceuticals has finalized the acquisition of 85% equity in Aequitas Healthcare.
- The acquisition follows earlier disclosures and updates from late June and early July 2026.
- This marks a significant strategic expansion for Jagsonpal Pharmaceuticals.
- The company has formally notified the stock exchange of the completed transaction.
Price Impact
More from JAGSNPHARM